Message from the Program Director
On behalf of Houston Methodist Division of Hematology and Oncology, I would like to thank you for your interest in our Hematology and Oncology Fellowship. I would like to share with you a brief overview of the program. The division of hematology and oncology at Houston Methodist Hospital has undergone a significant growth in the past decade and is composed of physicians and physician scientists that cover the breadth of hematology and medical oncology. Our vigorous clinical trials program offers innovative therapies to patients.
The goal of our fellowship is to train outstanding clinicians, clinician-scientists and translational researchers in hematology and oncology. The fellowship program enjoys a wealth of diverse clinical expertise and patient variety for hematology oncology. A broad and deep exposure to the clinical problems is made possible by two half-day continuity clinics a week for specialty general hematology and oncology.
The continuity clinics are staffed by the subspecialty faculty enhancing the learning experience. The fellows follow their own panel of patients throughout their training, greatly enhancing the clinical experience. The fellow’s clinic is supported by a medical assistant as well as a nurse. The hematology rotations include malignant hematology inpatient and outpatient, benign hematology rotation, bone marrow transplant rotation, transfusion and hematopathology rotation and a procedure rotation. The oncology rotations include outpatient breast, thoracic, GI, neuro-oncology, gynecology, sarcoma, melanoma, palliative care and radiation oncology.
In addition, fellows go to Legacy Clinic, federally qualified health center (FQHC) once a month to see variety of benign hematologic to oncologic metastatic disease in underserved population. Starting July 2019, Fellows will also be rotating to Ben Taub and Smith Clinic for part of their continuity clinic rotation.
Research is a required part of fellowship. The fellowship can be structured so that up to 12 months of the 36 months fellowship can be devoted to the research. A variety of research opportunities including laboratory-based research, big data mining and clinical and translational research are available. The mentorship committee includes a biostatistician, clinical researcher, and multiple translational researchers. In 2019, we are proud to have two fellows win the ASCO Merit award, one fellow win ASCO SITC merit award and two fellows chosen to participate at ASCO Vail workshop.
To facilitate exposure to various hematology oncology meetings, the first year fellows attend ASH annual meeting, the second year fellows attend San Antonio Breast cancer symposium and ASCO annual meeting. The third year fellows attend a board review course. In addition, they can attend additional meetings when presenting.
Our division is a close group. The faculty are friendly, approachable and committed to the fellowship and fellow’s education.
We appreciate your interest and look forward to meeting you,